Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: MK0954A-264 Filter Study (0954A-264)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial MK0954A-264 Filter Study for mild to severe hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK0954A-264 Filter

Snippet

Sponsor: Organon and Co | Conditions: Mild to Severe Hypertension | Phase 3 | Status: COMPLETED